柳氮磺胺吡啶治疗类风湿性关节炎：使皮疹患者脱敏。
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
作者信息
Bax D E, Amos R S
出版信息
Ann Rheum Dis. 1986 Feb;45(2):139-40. doi: 10.1136/ard.45.2.139.
Abstract
Sulphasalazine has been shown to be useful in the management of rheumatoid arthritis. However, its use may be complicated by a skin rash. Eight patients with a rash have undergone desensitisation, the aim of which was to achieve a daily dose of 2 g sulphasalazine. This was successful in five patients, partially successful in two, and failed in one patient. Desensitisation to sulphasalazine is a simple outpatient procedure, which subsequently allows the majority of patients developing a skin rash to continue treatment.
摘要
柳氮磺胺吡啶已被证明在类风湿性关节炎的治疗中有用。然而，其使用可能会因皮疹而变得复杂。八名出现皮疹的患者接受了脱敏治疗，目的是达到每日2克柳氮磺胺吡啶的剂量。五名患者成功，两名部分成功，一名患者失败。柳氮磺胺吡啶脱敏是一种简单的门诊程序，随后可使大多数出现皮疹的患者继续治疗。
相似文献
1
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.柳氮磺胺吡啶治疗类风湿性关节炎：使皮疹患者脱敏。
Ann Rheum Dis. 1986 Feb;45(2):139-40. doi: 10.1136/ard.45.2.139.
2
Sulphasalazine desensitisation in patients with arthritis.
Ir J Med Sci. 1994 May;163(5):238-9. doi: 10.1007/BF02943259.
3
Desensitization to sulphasalazine in patients with arthritis.关节炎患者对柳氮磺胺吡啶的脱敏作用
Clin Exp Rheumatol. 1993 Mar-Apr;11(2):169-70.
4
Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
Acta Paediatr. 1995 Aug;84(8):952-4. doi: 10.1111/j.1651-2227.1995.tb13803.x.
5
Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.溃疡性结肠炎患者对柳氮磺胺吡啶引起的皮疹进行脱敏治疗。
J Gastroenterol. 1994 Dec;29(6):772-5. doi: 10.1007/BF02349286.
6
Sulphasalazine desensitisation in rheumatoid arthritis.类风湿关节炎中柳氮磺胺吡啶脱敏疗法
Br Med J (Clin Res Ed). 1982 Jan 9;284(6309):118. doi: 10.1136/bmj.284.6309.118-b.
7
Desensitization for sulfasalazine skin rash.柳氮磺胺吡啶皮疹的脱敏治疗。
Ann Intern Med. 1984 Apr;100(4):512-4. doi: 10.7326/0003-4819-100-4-512.
8
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.柳氮磺胺吡啶治疗类风湿性关节炎：对出现皮疹的患者进行脱敏处理。
Ann Rheum Dis. 1987 May;46(5):421. doi: 10.1136/ard.46.5.421-b.
9
Toxicity of sulphasalazine in rheumatoid arthritis. Possible protective effect of rheumatoid factors and corticosteroids.柳氮磺胺吡啶在类风湿关节炎中的毒性。类风湿因子和皮质类固醇可能的保护作用。
Scand J Rheumatol. 1993;22(5):229-32. doi: 10.3109/03009749309095128.
10
Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a co-operating clinics study.类风湿关节炎中肠溶包衣柳氮磺胺吡啶的耐受性：一项合作诊所研究的结果。
Br J Rheumatol. 1990 Jun;29(3):201-4. doi: 10.1093/rheumatology/29.3.201.
引用本文的文献
1
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.低剂量脱敏疗法不能降低柳氮磺胺吡啶在类风湿关节炎中的毒性。
Ann Rheum Dis. 1996 May;55(5):328-30. doi: 10.1136/ard.55.5.328.
2
Sulphasalazine desensitisation in patients with arthritis.
Ir J Med Sci. 1994 May;163(5):238-9. doi: 10.1007/BF02943259.
3
Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.柳氮磺胺吡啶。其药理学特性及治疗类风湿关节炎疗效的综述。
Drugs. 1995 Jul;50(1):137-56. doi: 10.2165/00003495-199550010-00009.
4
Desensitisation to allopurinol.别嘌醇脱敏
Ann Rheum Dis. 1987 Jan;46(1):84. doi: 10.1136/ard.46.1.84.
5
Sulphasalazine in arthritis--an old drug rediscovered.
Clin Rheumatol. 1987 Sep;6(3):378-83. doi: 10.1007/BF02206836.
6
Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
Clin Rheumatol. 1987 Jun;6(2):244-50. doi: 10.1007/BF02201031.
7
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.柳氮磺胺吡啶治疗类风湿性关节炎：对出现皮疹的患者进行脱敏处理。
Ann Rheum Dis. 1987 May;46(5):421. doi: 10.1136/ard.46.5.421-b.
8
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.用于类风湿性关节炎的柳氮磺胺吡啶：774例患者长达1至11年的毒性监测
Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):420-3. doi: 10.1136/bmj.293.6544.420.
9
Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.缓慢起效药物：进展缓慢？类风湿关节炎中慢作用抗风湿药物（SAARDs）的应用
Ann Rheum Dis. 1992 Mar;51(3):424-9. doi: 10.1136/ard.51.3.424.
本文引用的文献
1
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.柳氮磺胺吡啶治疗类风湿性关节炎：柳氮磺胺吡啶与安慰剂及金硫代苹果酸钠的双盲对照研究
Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1102-4. doi: 10.1136/bmj.287.6399.1102.
2
Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.青霉胺与柳氮磺胺吡啶治疗类风湿性关节炎的比较：利兹-伯明翰试验。
Br Med J (Clin Res Ed). 1983 Oct 15;287(6399):1099-102. doi: 10.1136/bmj.287.6399.1099.
3
Sulphasalazine desensitisation.柳氮磺胺吡啶脱敏疗法。
Br Med J (Clin Res Ed). 1981 Jan 10;282(6258):110. doi: 10.1136/bmj.282.6258.110.
4
Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.柳氮磺胺吡啶：一种用于长期控制类风湿性关节炎的安全、有效药物。与金硫代苹果酸钠的比较。
Ann Rheum Dis. 1985 Mar;44(3):194-8. doi: 10.1136/ard.44.3.194.
Zotero 插件